Dengue Moment
For a country that has lived with dengue as a seasonal inevitability, the emergence of DengiAll, India’s indigenous single-shot dengue vaccine now in advanced trials in Delhi, is more than a scientific milestone.
For a country that has lived with dengue as a seasonal inevitability, the emergence of DengiAll, India’s indigenous single-shot dengue vaccine now in advanced trials in Delhi, is more than a scientific milestone.
The World Health Organization (WHO) has donated 2,160 doses of Ebola trial vaccine to Uganda to evaluate the efficacy of the vaccine in combating the virus which in the recent outbreak has killed a health worker in Kampala, the country's capital.
Indonesia is developing a new Tuberculosis (TB) vaccine to strengthen the fight against TB, which has claimed an average of 150,000 lives annually.
The landmark trial will evaluate the efficacy of India’s indigenous tetravalent dengue vaccine, DengiAll, developed by Panacea Biotec.
Specifically, the team compared the immune responses in people who were protected against CMV infection after receiving the older vaccine.
The Kandhamal district with no active case have turned covid-free zone while nine more districts with single digit active case are on the verge of becoming infection-free territories.
The state currently has 1,989 active Covid-19 cases while 10,41,836 patients including 108 on Wednesday recovering from the disease.
Covavax is currently under trial and has shown excellent results down to the age of 3 years, Poonawalla said while addressing an event at the Confederation of Indian Industries (CII).
The vaccination drive in the country has been ramped up through the availability of more vaccines, advanced visibility of vaccine availability to states and UT for enabling better planning by them and streamlining the vaccine supply chain.
Responding to a question during the Question House in the Lower House, he also said that the Omicron surfaced on November 1 and on November 24 this was reported in South Africa.
